“Advancements in Genetic Therapies & Enzyme Inhibitors for Alkaptonuria Treatment”
- A prominent trend in the treatment of alkaptonuria is the growing integration of advanced genetic therapies and enzyme inhibitors.
- These therapies aim to target the root cause of the disease, reducing the accumulation of homogentisic acid, which causes joint and heart complications
- For instance, enzyme replacement therapies are showing promise in managing symptoms and slowing disease progression, offering patients improved quality of life.
- These advancements are transforming alkaptonuria management, driving the demand for next-generation treatments with enhanced efficacy and fewer side effects
